Objectives: This study examines N-terminal pro-brain natriuretic peptide (NT-proBNP) variability in plasma and urine samples of stable heart failure patients during a 24-month follow-up.
Design: prospective study
Setting: Teaching hospital based study Patients: We followed 74 clinically and functionally stable patients (NYHA class=2±0.5) out of 114 diagnosed of heart failure, measuring NT-proBNP plasma and urine levels in three stages (basal, 12 months and 24 months).
Results: During the follow-up we found significant differences in mean urinary levels (p<0.01), but no changes were found in plasma. Bland-Altman plots showed few variations in plasma percentages in the three intervals (stage I - basal; stage II - stage I; stage II - basal) with a coefficient of reproducibility (CR) of 22%, 21%; and 25%, respectively. Changes in NT-proBNP urinary levels had a CR of 7.1%, 6.8% and 9.4%. Finally, we found a good correlation between plasma and urinary levels (p<0.0001) and between the different NT-proBNP plasma (p<0.0001) and urine measurements (p<0.0001).
Conclusions: NT-proBNP plasma and urine levels show good stability in a 24-month follow-up of stable heart failure patients. As a result, assessment of urinary and plasma NT-proBNP concentrations may be a meaningful tool to monitor the follow-up of patients with heart failure. The results suggest that variations in peptide concentrations exceeding 22% in plasma and 7% in urine in a 12-month follow-up and 25% and 9% in a 24-month follow-up may be pathophysiological relevant.
- natriuretic peptides
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.